Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  1993-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/JAC/31.6.865PMID 8360125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Centrifugation injury of gram-negative bacteria.

  1991cited by this paper
• Factors influencing the uptake of norfloxacin by Escherichia coli.

  1991cited by this paper
• Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains.

  1991cited by this paper
• Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.

  1991cited by this paper
• Biphasic kinetics of bacterial killing by quinolones.

  1991cited by this paper
• Identification and characterization of porins in Pseudomonas aeruginosa.

  1991cited by this paper
• Uptake of 3H-norfloxacin in methicillin-resistant Staphylococcus aureus.

  1991cited by this paper
• Mechanism of quinolone uptake into bacterial cells.

  1991cited by this paper
• Fluoroquinolone antimicrobial agents.

  1991cited by this paper
• Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa

  1991cited by this paper
• A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.

  1991cited by this paper
• Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones

  1990cited by this paper
• The accumulation of five quinolone antibacterial agents by Escherichia coli.

  1990cited by this paper
• Mechanism of action of lomefloxacin

  1990cited by this paper
• Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli

  1990cited by this paper
• Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation

  1989cited by this paper
• Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin

  1989cited by this paper
• Endogenous active efflux of norfloxacin in susceptible Escherichia coli

  1988cited by this paper
• Routes of quinolone permeation in Escherichia coli

  1988cited by this paper
• Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa

  1987cited by this paper
• New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.

  1986cited by this paper
• Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.

  1986cited by this paper
• An investigation of the hydrophobicity of the quinolones.

  1986cited by this paper
• Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli

  1986cited by this paper
• Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth

  1985cited by this paper
• Molecular basis of bacterial outer membrane permeability.

  1985cited by this paper
• Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

  1985cited by this paper
• The in vitro and in vivo activity of ciprofloxacin

  1984cited by this paper

• Carrier-mediated transport as a common route of antibiotic ingress into bacteria

  2025cites this paper
• Reactive metabolic byproducts contribute to antibiotic lethality under anaerobic conditions.

  2022cites this paper
• Unravelling microbial efflux through mathematical modelling.

  2022cites this paper
• High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli

  2022influential citation
• Property space mapping of Pseudomonas aeruginosa permeability to small molecules

  2022cites this paper
• Microscopic Approach to Intrinsic Antibiotic Resistance.

  2021cites this paper
• Fast bacterial growth reduces antibiotic accumulation and efficacy

  2021cites this paper
• Single-cell microfluidics facilitates the rapid quantification of antibiotic accumulation in Gram-negative bacteria

  2020cites this paper
• Cytochrome P450-mediated N-demethylation of noscapine by whole-cell biotransformation: process limitations and strategies for optimisation

  2020cites this paper
• Evaluation of the intracellular accumulation of fluoroquinolones in mycobacteria by fluorometric assays

  2020cites this paper
• Defining new chemical space for drug penetration into Gram-negative bacteria

  2020cites this paper
• Permeability barriers of Gram‐negative pathogens

  2020cites this paper
• Outer Membrane Porins.

  2019cites this paper
• Antibiotic transport kinetics in Gram-negative bacteria revealed via single-cell uptake analysis and mathematical modelling

  2019cites this paper
• Site-Directed Mutagenesis Reveals Crucial Residues in Escherichia coli Resistance-Nodulation-Division Efflux Pump OqxB

  2019cites this paper
• Flow Cytometric Analysis of Efflux by Dye Accumulation

  2019cites this paper
• Label-free single-cell microfluidics reveals antibiotic transport kinetics in Gram-negative bacteria

  2019cites this paper
• Bifurcation kinetics of drug uptake by Gram-negative bacteria

  2017cites this paper
• Understanding and Sensitizing Density-Dependent Persistence to Quinolone Antibiotics.

  2017cites this paper
• IN VITRO RELEASE AND PHARMACOKINETICS OF ENROFLOXACIN PHBV MICROSPHERE IN RATS

  2016cites this paper
• Dynamical Model of Drug Accumulation in Bacteria: Sensitivity Analysis and Experimentally Testable Predictions

  2016cites this paper
• Obg and Membrane Depolarization Are Part of a Microbial Bet-Hedging Strategy that Leads to Antibiotic Tolerance.

  2015cites this paper
• Preclinical investigation of the pharmacokinetics, metabolism, and protein and red blood cell binding of DRDE-07: a prophylactic agent against sulphur mustard

  2014cites this paper
• Reactions and behavior relevant to chemical and physical properties of various veterinary antibiotics in soil

  2014cites this paper
• Cationic Methacrylate Polymers as Topical Antimicrobial Agents against Staphylococcus aureus Nasal Colonization

  2014cites this paper
• Tissue distribution of enrofloxacin in African clawed frogs (Xenopus laevis) after intramuscular and subcutaneous administration.

  2013cites this paper
• Antibiyotiklerin Kaynakları Ve Çevresel Etkileri

  2012cites this paper
• Bactericidal properties of pradofloxacin against veterinary pathogens.

  2012cites this paper
• Antibiotics: mode of action and mechanisms of resistance

  2011cites this paper
• Fluoroquinolone Efflux by the Plasmid-Mediated Multidrug Efflux Pump QacB Variant QacBIII in Staphylococcus aureus

  2010cites this paper
• Pharmacokinetics and toxicity of ciprofloxacin in adult horses.

  2010cites this paper
• Enhanced Bacterial Uptake and Bactericidal Properties of Ofloxacin Loaded on Bioadhesive Hydrogels Against Pseudomonas aeruginosa

  2010cites this paper
• Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.

  2009cites this paper
• Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.

  2007cites this paper
• The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.

  2006cites this paper
• La proteïna TolC de "Klebsiella oxytoca"

  2006cites this paper
• Pharmacokinetics of voriconazole after oral and intravenous administration to horses.

  2006cites this paper
• Contribución al estudio de los mecanismos moleculares de la resistencia a ciprofloxacina en "Streptococcus pneumoniae"

  2005cites this paper
• Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.

  2005cites this paper
• Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.

  2005cites this paper
• In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.

  2004cites this paper
• Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.

  2003cites this paper
• Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin.

  2002cites this paper
• Evidence of Active Efflux in Resistance to Ciprofloxacin and to Ethidium Bromide by Mycoplasma hominis

  2002cites this paper
• Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus.

  2001cites this paper
• Bioequivalence of four preparations of enrofloxacin in poultry.

  2001cites this paper
• Structure-Fluorescence Relationships in Antimicrobial Fluoroquinolones (AMFQs)

  2000cites this paper
• Problemática del uso de enrofloxacina en la avicultura en México

  2000cites this paper
• Effect of fluorine substitution on the interaction of lipophilic ions with the plasma membrane of mammalian cells.

  2000influential citation
• Penetration of Rufloxacin into the Cerebrospinal Fluid in Patients with Inflamed and Uninflamed Meninges

  2000cites this paper
• Evidence for an Efflux Pump Mediating Multiple Antibiotic Resistance in Salmonella enterica Serovar Typhimurium

  2000cites this paper
• Ofloxacin-Loaded Liposomes: In Vitro Activity and Drug Accumulation in Bacteria

  2000cites this paper
• Antimicrobial activity and accumulation of moxifloxacin in quinolone-susceptible bacteria.

  1999cites this paper
• The use of fluoroquinolones in veterinary dermatology.

  1999cites this paper
• Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.

  1999cites this paper
• Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.

  1999cites this paper
• Analysis of the mechanisms of quinolone resistance in clinical isolates of citrobacter freundii

  1999cites this paper
• Accumulation of Norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis

  1998cites this paper
• Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus.

  1998cites this paper
• Antibacterial drug therapy. Focus on new drugs.

  1998cites this paper
• Pharmacokinetics, Pharmacodynamics, and Tolerability Profile of Clinafloxacin

  1998cites this paper
• Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus

  1996cites this paper
• Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation.

  1995cites this paper
• In-vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis.

  1994cites this paper
• Activity of 4-quinolones against Pseudomonas aeruginosa.

  1994cites this paper
• New quinolones and gram-positive bacteria

  1994cites this paper
• Quinolone resistance in veterinary isolates of Salmonella.

  1994cites this paper